Organization | Harokopio University

Harokopio University Report issue

Academic/Hospital Phase 2

Founded: Kallithea Greece (1990)

Organization Overview

First Clinical Trial

2007

NCT00971113

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Harokopio University | Harokopio University of Athens | Harokopio University, School of Health Sciences and Education

Active Ingredients

Drugs in Phase 2 Trials (1)

mastiha (2 trials)

Drugs in Other Trials (14)

beta-glucans (1 trial)

butter (1 trial)

cabernet sauvignon (1 trial)

ibuprofen (motrin) (1 trial)

mastiha oil (2 trials)

mushrooms (1 trial)

oleocanthal (1 trial)

olive oil (2 trials)

sc-fos (1 trial)

sideritis euboea extract (1 trial)

tahini (1 trial)

thiamine (1 trial)

tsipouro (1 trial)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Fatty Liver (Phase 1)

Inflammatory Bowel Diseases (Phase 2)

Intestinal Diseases (Phase 2)

Liver Diseases (Phase 1)

Non-alcoholic Fatty Liver Disease (Phase 1)

Overview

Highest Phase: Phase 2
# of Trials: 18
# of Trial APIs: 15